BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 7086705)

  • 21. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
    Zehender H; Witte EC; Wolff HP; Patscheke H
    Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of trapidil derivatives on arachidonic acid- and prostaglandin endoperoxide analogue- induced platelet aggregation and thromboxane A2 formation.
    Heinroth I; Block HU; Mest HJ
    Biomed Biochim Acta; 1984; 43(8-9):S389-92. PubMed ID: 6440555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thromboxane A2 and prostaglandin endoperoxide receptors in platelets and vascular smooth muscle.
    Saussy DL; Mais DE; Knapp DR; Halushka PV
    Circulation; 1985 Dec; 72(6):1202-7. PubMed ID: 2998641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
    Mais DE; Liel N; Halushka PV
    Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
    Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
    Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
    Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
    Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide.
    Tesfamariam B
    J Hypertens; 1994 Jan; 12(1):41-7. PubMed ID: 8157943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive antagonism at thromboxane receptors in human platelets.
    Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
    Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin F2 alpha antagonizes thromboxane A2-induced human platelet aggregation.
    Hung SC; Ghali NI; Venton DL; Le Breton GC
    Prostaglandins; 1982 Aug; 24(2):195-206. PubMed ID: 6293001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient concentrations and agonist potency of PGH2 in platelet activation by endogenous arachidonate.
    Hornberger W; Patscheke H
    Eicosanoids; 1989; 2(4):241-8. PubMed ID: 2517034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The human thromboxane A2 receptor alpha isoform (TP alpha) functionally couples to the G proteins Gq and G11 in vivo and is activated by the isoprostane 8-epi prostaglandin F2 alpha.
    Kinsella BT; O'Mahony DJ; Fitzgerald GA
    J Pharmacol Exp Ther; 1997 May; 281(2):957-64. PubMed ID: 9152406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets.
    Nakano T; Hanasaki K; Arita H
    FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormal platelet response to thromboxane A2.
    Wu KK; Le Breton GC; Tai HH; Chen YC
    J Clin Invest; 1981 Jun; 67(6):1801-4. PubMed ID: 6263954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The roles of LAT in platelet signaling induced by collagen, TxA2, or ADP.
    Cho MJ; Pestina TI; Steward SA; Jackson CW; Kent Gartner T
    Biochem Biophys Res Commun; 2002 Apr; 292(4):916-21. PubMed ID: 11944902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostacyclin potentiates 13-azaprostanoic acid-induced platelet deaggregation.
    Parise LV; Venton DL; Le Breton GC
    Thromb Res; 1982 Dec; 28(6):721-30. PubMed ID: 6301090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
    Halushka PV; Boehm A; Mais DE
    Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandin H2 directly lowers human platelet cAMP levels.
    Rybicki JP; Le Breton GC
    Thromb Res; 1983 Jun; 30(5):407-14. PubMed ID: 6310815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.